Moldovan president, Russian envoy to hash over bilateral ties and breakaway TransnistriaRussian Politics & Diplomacy July 25, 14:43
US will either have to put up with North Korea’s nuclear weapons or use force — expertWorld July 25, 14:33
Kremlin refrains from comments on media allegations about Tillerson’s possible resignationRussian Politics & Diplomacy July 25, 14:03
Kremlin comments on US potentially funneling weapons to KievRussian Politics & Diplomacy July 25, 13:45
Kremlin says Russia, US not negotiating renewal of adoptionsRussian Politics & Diplomacy July 25, 13:37
Russian Ice Hockey Federation to render assistance to banned forward ZaripovSport July 25, 13:27
Press review: Malorossiya as an EU taboo and Moldova’s animosity to Russian peacekeepersPress Review July 25, 13:00
Poll reveals most Russians familiar with Jehovah’s Witnesses support its banSociety & Culture July 25, 12:11
Lithuania keeps tipping off NATO allies on Russian-Chinese naval drills in Baltic SeaMilitary & Defense July 25, 12:02
KALUGA, June 5. /TASS/. A new pharmaceutical plant, Nearmedic Pharma, located on the territory of a major innovation and industrial Kaluga region, in central Russia, is starting manufacturing medicines.
The project worth $73 million is implemented in cooperation with the national holding company Nearmedic and the Russian Corporation of Nanotechnologies, the press service of Nearmedic Plus told TASS.
The new plant complies with international standards GMP, ISO and FDA. The total annual output reaches up to 100 million medical products, including anti-viral medications.
"The plant is unique as the whole cycle from the synthesis of incoming substances to manufacturing of finished pharma products comes in the framework of one production unit and the product range is the company’s innovations," the press service said.
All the pharmaceutical companies in Russia's Kaluga region are united in a single pharma cluster which now consists of 54 companies.